Effect of a high concentration perfluorocarbon emulsion on platelet function.

Area of Science:

• Biomedical Science
• Pharmacology
• Hematology

Background:

• Perfluorocarbon (PFC) and lipid emulsions can alter platelet function.
• Platelet activation may contribute to PFC-induced side effects.

Purpose of the Study:

• To investigate the effect of a concentrated perfluorooctylbromide (PFOB) emulsion on porcine and human platelet activation and function.
• To determine if PFOB impacts platelet aggregation and calcium flux.

Main Methods:

• Ex-vivo porcine platelet aggregation was measured pre- and post-infusion of PFOB or control emulsions.
• In vitro human platelet calcium flux was assessed in the presence of PFOB or control emulsions.
• Platelet aggregation was stimulated by collagen, ADP, or arachidonic acid (AA); calcium flux by A23187 or AA.

Main Results:

• PFOB emulsion infusion (3 ml/kg) significantly inhibited ex-vivo porcine platelet aggregation stimulated by collagen, ADP, and AA.
• Inhibition of platelet aggregation was dose-dependent, with lower doses showing reduced effects.
• In vitro human platelet calcium flux stimulated by A23187 or AA was inhibited by 1% (v/v) PFOB emulsion.
• Similar inhibitory effects on calcium flux were observed with Fluosol and Intralipid emulsions.

Conclusions:

• Highly concentrated perfluorooctylbromide (PFOB) emulsions inhibit both ex-vivo porcine and in vitro human platelet function.
• The observed inhibition of platelet aggregation and calcium flux is dose-dependent.
• PFOB emulsions may modulate platelet activation, potentially influencing PFC-related side effects.